Search Results - "rouillon, cléa"

The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics by Lelong, Margaux, Josien, Régis, Coste-Burel, Marianne, Rimbert, Marie, Bressollette-Bodin, Céline, Nancey, Stéphane, Bouguen, Guillaume, Allez, Matthieu, Serrero, Mélanie, Caillo, Ludovic, Rouillon, Cléa, Blanc, Pierre, Laharie, David, Olivier, Raphaël, Peyrin-Biroulet, Laurent, Dib, Nina, De Maissin, Astrid, Montuclard, Céline, Trang-Poisson, Caroline, Vavasseur, Fabienne, Gallot, Géraldine, Berthome, Mathilde, Braudeau, Cécile, Chevreuil, Justine, Bourreille, Arnaud, Le Berre, Catherine

“…Background Patients with inflammatory bowel disease (IBD) may have a modified immune response to SARS-CoV-2. The objectives were to evaluate the prevalence of…”
Get full text

Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options by Rodari, Marco M., Cazals-Hatem, Dominique, Uzzan, Mathieu, Martin Silva, Nicolas, Khiat, Anis, Ta, Minh Chau, Lhermitte, Ludovic, Touzart, Aurore, Hanein, Sylvain, Rouillon, Cléa, Joly, Francisca, Elmorjani, Adrienne, Steffann, Julie, Cerf-Bensussan, Nadine, Parlato, Marianna, Charbit-Henrion, Fabienne

“…Purpose Hyper activation of the JAK-STAT signaling underlies the pathophysiology of many human immune–mediated diseases. Herein, the study of 2 adult patients…”
Get full text

Risk of incident cancer in patients with Inflammatory Bowel Disease with prior breast cancer: a multicenter cohort study by Le Cosquer, Guillaume, Kirchgesner, Julien, Gilletta De Saint Joseph, Cyrielle, Seksik, Philippe, Amiot, Aurélien, laharie, david, nachury, maria, rouillon, cléa, abitbol, vered, nuzzo, alexandre, nancey, stéphane, fumery, mathurin, biron, amélie, richard, nicolas, altwegg, romain, moussata, driffa, caron, benedicte, vidon, mathias, reenaers, catherine, uzzan, mathieu, reimund, Jean-marie, serrero, mélanie, simon, marion, benezech, alban, goutorbe, félix, pelletier, Anne-laure, caillo, ludovic, vaysse, charlotte, poullenot, florian

“…Breast cancer is the most common malignancy observed in patients with inflammatory bowel diseases (IBD). The aim of our study was to evaluate incident cancer…”
Get full text

SAT-007-Survival and risk factors of mortality after emergency transjugular intrahepatic portosystemic shunt for uncontrolled acute variceal bleeding caused by cirrhosis-related portal hypertension by Allaire, Manon, Walter, Aurélie, Ollivier-Hourmand, Isabelle, Rouillon, Cléa, Sutter, Olivier, Seror, Olivier, Amathieu, Roland, Ganne, Nathalie, Nault, Jean Charles, Dao, Thong

Get full text

1179 PERSISTENCE, EFFICACY AND TOLERANCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCH FROM INTRAVENOUS INFLIXIMAB IN IBD PATIENTS IN REMISSION:: ONE-TEAR RESULTS FROM A MULTICENTER PROSPECTIVE COHORT by Mathieu, Nicolas, Heluwaert, Frédéric, Rivière, Pauline, Hebuterne, Xavier, Chupin, Antoine, Abitbol, Vered, Guillaume, Bouguen, Vuitton, Lucine, Allez, Matthieu, Montuclard, Celine, Nancey, Stephane, Biron, Amelie, Wils, Pauline, Gilletta, Cyrielle, de Maissin, Astrid, Altwegg, Romain, Chanteloup, Elise, Plastaras, Laurianne, Soune, Philippe Ah, Bourreille, Arnaud, Bouhnik, Yoram, Seksik, Philippe, Simon, Marion, Uzzan, Mathieu, andrau, Pierre, Rouillon, Clea, Arondel, Yves, Peyrin-Biroulet, Laurent, Laharie, David, Vicaut, Eric, Hupé, Marianne

Get full text

Tu1768 PERSISTENCE OF SUBCUTANEOUS INFLIXIMAB AFTER SWITCHING FROM INTRAVENOUS IN A FRENCH NATIONAL COHORT OF IBD PATIENTS IN REMISSION by Mathieu, Nicolas, Rivière, Pauline, Heluwaert, Frédéric, Hebuterne, Xavier, Chupin, Antoine, Guillaume, Bouguen, Vuitton, Lucine, Allez, Matthieu, montuclard, celine, Nachury, Maria, Nancey, Stephane, Biron, Amelie, Giletta, Cyrielle, Abitbol, Vered, Altwegg, Romain, de maissin, astrid, Plastaras, Laurianne, Soune, Philippe Ah, Bourreille, Arnaud, Bouhnik, Yoram, Seksik, Philippe, chanteloup, Elise, Simon, Marion, Uzzan, Mathieu, andrau, Pierre, Rouillon, Clea, arondel, yves, Peyrin-Biroulet, Laurent, Laharie, David

Get full text

Sa1820 RISK OF INCIDENT CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH PRIOR BREAST CANCER : A MULTICENTRE COHORT STUDY by Cosquer, Guillaume Le, Gilletta, Cyrielle, Amiot, Aurelien, Rivière, Pauline, Nachury, Maria, Rouillon, Clea, Bouhnik, Yoram, Abitbol, Vered, Nancey, Stephane, Fumery, Mathurin, Savoye, Guillaume, Biron, Amelie, Picon, Laurence, Peyrin-Biroulet, Laurent, Vidon, M.M., Reenaers, Catherine, Simon, Marion, Caron, Bénédicte, Serrero, Melanie, Altwegg, Romain, BENEZECH, Alban, Goutorbe, Felix, Rahier, Jean-Francois, Beaugerie, Laurent, Pelletier, Anne-Laure, Caillo, Ludovic, Laharie, David, Poullenot, Florian

Get full text

Mo1899 – Prognostic Factors for Long-Term Adalimumab Treatment in Crohn’s Disease : A Multicenter Experience by Pariente, Benjamin, Duveau, Nicolas, Perignon, Claire-Anne, Lepeut, Gabriel, Lahaye, Anouck, baut, Guillaume le, Rouillon, Clea, Yzet, Clara, Loreau, Julien, Wils, Pauline, Nachury, Maria, Fumery, Mathurin, Viennot, Stephanie

Get full text

Host-microbiota relationship in the pathophysiology of aseptic abscess syndrome: protocol for a multicentre case-control study (ABSCESSBIOT) by Trefond, Ludovic, Billard, Elisabeth, Pereira, Bruno, Richard, Damien, Vazeille, Emilie, Bonnet, Richard, Barnich, Nicolas, Andre, Marc

“…Aseptic abscess (AA) syndrome is a rare disease whose pathophysiology is unknown. It is often associated with inflammatory bowel disease and characterised by…”
Get full text

Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study by Briot, C, Faure, P, Parmentier, A L, Nachury, M, Trang, C, Viennot, S, Altwegg, R, Bulois, P, Thomassin, L, Serrero, M, Ah-Soune, P, Gilletta, C, Plastaras, L, Simon, M, Dray, X, Caillo, L, Del Tedesco, E, Abitbol, V, Zallot, C, Degand, T, Rossi, V, Bonnaud, G, Colin, D, Morel, B, Winkfield, B, Danset, J B, Filippi, J, Amiot, A, Attar, A, Levy, J, Peyrin-Biroulet, L, Vuitton, L

“…Standard high-volume polyethylene glycol [PEG] bowel preparations [PEG-4L] are recommended for patients with inflammatory bowel disease [IBD] undergoing…”
Get full text